Kunxiang Gong
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Antibody-Drug Conjugates Against Multidrug-Resistant Cancers: Biomarker-Guided Patient Selection, Payload Engineering, Linker Chemistry, and Bystander Effects.
Journal: Cancer letters
Published: May 25, 2026
The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 10, 2025
Triptonide-mediated PTGS2 Inhibition Induces Autophagic Cell Death to Suppress the Progression of Triple-negative Breast Cancer and Epithelial Ovarian Cancer.
Journal: International journal of biological sciences
Published: October 30, 2025
Platelet-activating factor induces ferroptosis by binding to ATF3 and inhibiting the SLC7A11/GPX4 axis to suppress the progression of endometrial carcinoma.
Journal: Biology direct
Published: October 01, 2025
Therapeutic mechanism of hederagenin, an active component in Guizhi Fuling Pellets, against cervical cancer in nude mice
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: July 17, 2025
Parabacteroides goldsteinii and its metabolite 7-KLCA attenuate endometriosis via TGR5 to reprogram macrophages by modulating the PPARγ/GPR132 axis.
Journal: NPJ biofilms and microbiomes
Published: July 02, 2025
Unveiling the Role of Immune Cells and Plasma Metabolites in Breast Cancer Risk: A Mendelian Randomization and Mediation Analysis.
Journal: Current pharmaceutical biotechnology
Published: October 30, 2024
Mechanism of berbamine-mediated DNA damage in synovial fibroblasts to alleviate rheumatoid arthritis.
Journal: European journal of pharmacology
Published: October 19, 2024
Phosphocholine inhibits proliferation and reduces stemness of endometrial cancer cells by downregulating mTOR-c-Myc signaling.
Journal: Cellular and molecular life sciences : CMLS
Published: August 03, 2024
ZSWIM4 inhibition improves chemosensitivity in epithelial ovarian cancer cells by suppressing intracellular glycine biosynthesis.
Journal: Journal of translational medicine
Published: November 13, 2023
Last Updated: 09/26/2026